![]() |
|
|
Vol. 285, Issue 1, 228-235, April 1998
IIb
3: Evidence for a Common Binding Site
for Cyclic Arginyl-Glycinyl-Aspartic Acid Peptides and Nonpeptides
Departments of
Cellular Biochemistry (A. W., S. M. H.),
Protein
Biochemistry (K. J.),
Macromolecular Sciences (D. B.),
Synthetic
Chemistry (S. W. L., W. C., J. R. H.),
Medicinal Chemistry
(J. S., F. A., T. W. K., W. B.), and
Pharmacology (A. J. N.,
D. A. P., J. M. S.), SmithKline Beecham Pharmaceuticals, King of
Prussia, Pennsylvania
The aggregation of activated platelets is mediated by the binding of
fibrinogen to its cell surface receptor, the integrin
IIb
3. The recognition of fibrinogen by
IIb
3 depends, in part, on the tripeptide
sequence Arg-Gly-Asp (RGD) in the adhesive protein. The interactions of
a cyclic RGD-containing pentapeptide, [3H]-SK&F-107260,
and a 1,4-benzodiazepine-based nonpeptide [3H]-SB-214857,
with purified
IIb
3 have been
investigated. Both compounds potently inhibit platelet aggregation at
submicromolar concentrations. Binding of both
[3H]-SK&F-107260 (Kd = 1.19 nM)
and [3H]-SB-214857 (Kd = 1.85 nM)
to
IIb
3 is of high affinity and fully
reversible. The binding is monophasic, indicating a single class of
noncooperative binding sites. The two radioligands exhibited similar
values in binding to
IIb
3 purified on an
RGD-affinity column (Bmax = 0.2 mol/mol
IIb
3) or to
IIb
3 purified over a lentil lectin column
(Bmax = 0.03 mol/mol
IIb
3),
suggesting that SK&F-107260 and SB-214857 interact with the same
population of receptors. Binding of [3H]-SK&F-107260 and
[3H]-SB-214857 to
IIb
3
require divalent cations, Mg++, Ca++ and
Mn++ are able to support binding, with Mn++
being the most effective. Thirteen
IIb
3
antagonists, including four linear and three cyclic RGD peptides, five
peptidomimetics, the fibrinogen
-chain dodecapeptide (HHLGGAKQAGDV)
and the snake venom protein, echistatin, complete for
[3H]-SK&F-107260 or [3H]-SB-214857 binding
to
IIb
3. The affinity constants
(Ki) of these compounds, determined by the two
radioligand binding assays, are similar. Furthermore, these compounds
exhibit the same rank order of potency in inhibiting
biotinylated-fibrinogen binding to
IIb
3.
Scatchard plot analyses of the [3H]-SK&F-107260 binding
isotherms in the presence of unlabeled SB-214857 and
-chain
dodecapeptide reveal competitive-type antagonism, indicating that
SB-214857,
-chain dodecapeptide and SK&F-107260 interact with
mutually exclusive binding sites on
IIb
3.